Medical nutrition therapy as a potential complementary treatment for psoriasis—five case reports

Alternative Medicine Review, Sept, 2004 by Amy C. Brown, Michelle Hairfield, Douglas G. Richards, David L. McMillin, Eric A. Mein, Carl D. Nelson

(22.) Pagano J. Healing Psoriasis: The Natural Alternative. Englewood Cliffs, NJ: The Pagano Organization, Inc.; 1991.

(23.) D'Amico E, Palazzi C, Capani F. Remission of psoriatic arthritis alter porto-caval anastomosis in a patient with primary biliary cirrhosis. J Rheumatol 1999;26:236.

(24.) Menzel I, Holzmann H. Reflections on seborrheic scalp eczema and psoriasis capillitii in relation to intestinal mycoses. Z Hautkr 1986;61:451-454. [Article in German]

(25.) Yates VM, Watkinson G, Kelman A. Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis. Br J Dermatol 1982;106:323-330.

(26.) Barry RE, Salmon PR, Read AE, Warin RP. Mucosal architecture of the small bowel in cases of psoriasis. Gut 1971;12:873-877.

(27.) Michaelsson G, Kraaz W, Gerden B, et al. Increased lymphocyte infiltration in duodenal mucosa from patients with psoriasis and serum IgA antibodies to gliadin. Br J Dermatol 1995;133:896-904.

(28.) Michaelsson G, Kraaz W, Hagforsen E, et al. Psoriasis patients have highly increased numbers of tryptase-positive mast cells in the duodenal stroma. Br J Dermatol 1997;136:866-870.

(29.) Humbert P, Bidet A, Treffel P, et al. Intestinal permeability in patients with psoriasis. J Dermatol Sci 1991;2:324-326.

(30.) Hamilton I, Fairris GM, Rothwell J, et al. Small intestinal permeability in dermatological disease. QJ Med 1985;56:559-567.

(31.) Ernst E. Colonic irrigation and the theory of autointoxication: a triumph of ignorance over science. J Clin Gastroenterol 1997;24:196-198.

(32.) Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 1996;20:411-417.

(33.) Person JR, Bernhard JD. Autointoxication revisited. J Am Acad Dermatol 1986;15:559-563.

(34.) Glinski W, Jablonska S, Imiela J, et al. Continuous peritoneal dialysis for treatment of psoriasis. I. Depletion of PMNL as a possible factor for clearing of psoriatic lesions. Arch Dermatol Res 1979;265:337-341.

(35.) McEvoy J, Kelly AM. Psoriatic clearance during haemodialysis. Ulster Med J 1976;45:76-78.

(36.) Muston HL, Conceicao S. Remission of psoriasis during haemodialysis. Br Med J 1978;1:480-481.

(37.) Twardowski ZJ. Abatement of psoriasis and repeated dialysis. Ann Intern Med 1977;86:509-510.

(38.) Landsford FD. Psoriasis. In: McGarey WA, ed. Physicians Reference Notebook. Virginia Beach, VA: A.R.E. Press: 1983:303-309.

(39.) Mcmillin DL, Richards DG, Mein EA, Nelson CD. Systemic aspects of psoriasis. An integrative model based on intestinal etiology. Integr Med 2000;2:105-113.

(40.) Mein E. Keys to Health. New York, NY: Harper & Row Publishers, Inc.; 1989.

(41.) Gottlieb AB, Kang S, Linden KG, et al. Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis. Clin Immunol 2004;111:28-37.

(42.) McHenry PM, Doherty VR. Psoriasis: an audit of patients' views on the disease and its treatment. Br J Dermatol 1992:127:13-17.